Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Mundipharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (114)
ARTG (90)
Australian public assessment report (AusPar) (9)
Prescription medicine registration (2)
Cancellation or suspension (1)

Date

2024 (16)
2023 (1)
2022 (62)
2021 (3)
2020 (28)
2019 (5)
2018 (7)
2017 (19)
2016 (5)
2015 (8)
2014 (7)
2013 (13)
2012 (1)
2011 (2)
2010 (7)
2005 (6)
2003 (3)
2001 (3)
2000 (7)
1999 (4)
1996 (1)
1995 (3)
1993 (3)
1991 (2)

Search

Sponsor content

216 result(s) found, displaying 141 to 150

TARGIN oxycodone hydrochloride / naloxone hydrochloride 30/15mg modified release tablets blister pack (216280)

24 September 2014

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TARGIN oxycodone hydrochloride / naloxone hydrochloride 30/15mg modified release tablets blister pack.
DILAUDID-HP hydromorphone hydrochloride 50mg/5mL injection ampoule Cancelled under s30(1)(c)

4 August 2017

Cancellation by sponsor

Requested by Mundipharma Pty Ltd
OXYCONTIN oxycodone hydrochloride 5mg modified release tablet blister pack Cancelled under s30(1)(c)

30 June 2017

Cancellation by sponsor

Requested by Mundipharma Pty Ltd
OXYCONTIN oxycodone hydrochloride 15mg modified release tablet bottle Cancelled under s30(1)(c)

30 June 2017

Cancellation by sponsor

Requested by Mundipharma Pty Ltd
OXYCONTIN oxycodone hydrochloride 30mg modified release tablet bottle Cancelled under s30(1)(c)

30 June 2017

Cancellation by sponsor

Requested by Mundipharma Pty Ltd
OXYCONTIN oxycodone hydrochloride 60mg modified release tablet bottle Cancelled under s30(1)(c)

30 June 2017

Cancellation by sponsor

Requested by Mundipharma Pty Ltd
OXYCONTIN oxycodone hydrochloride 80mg modified release tablet bottle Cancelled under s30(1)(c)

30 June 2017

Cancellation by sponsor

Requested by Mundipharma Pty Ltd
OXYCONTIN oxycodone hydrochloride 20mg modified release tablet bottle Cancelled under s30(1)(c)

30 June 2017

Cancellation by sponsor

Requested by Mundipharma Pty Ltd
OXYCONTIN oxycodone hydrochloride 40mg modified release tablet bottle Cancelled under s30(1)(c)

30 June 2017

Cancellation by sponsor

Requested by Mundipharma Pty Ltd
OXYCONTIN oxycodone hydrochloride 10mg modified release tablet bottle Cancelled under s30(1)(c)

30 June 2017

Cancellation by sponsor

Requested by Mundipharma Pty Ltd

Pages

First page
Previous page
…
Page 11
Page 12
Page 13
Page 14
Current page 15
Page 16
Page 17
Page 18
Page 19
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.